Aether Industries Ltd. · NSE:AETHER
Aether Industries — Q3 FY25 Earnings Presentation
25 slides from Aether Industries's earnings presentation, Jan 18, 2025
Slide 1: Investor Presentation submission letter to stock exchanges
January 18, 2025 Ref. No.: AIL/SE/77/2024-25 To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai-400001, MH. Mumbai-400051, MH. Scrip Code: 543534 Symbol: AETHER Dear Madam / Sir, Subject: In
Slide 2: Jan 2025
Jan 2025
Slide 3: Disclaimer
DISCLAIMER This investor presentation has been prepared by Aether Industries Limited and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof), delivered or supplied, should no
Slide 4: Agenda
Agenda Innovation for a Sustainable Future 01 Aether Today (04) 02 Aether’s Business Segments (05) 03 Highlights (06) 04 Business Models (07) 05 Financial Snapshots (08) 06 Announcements (11) 07 Accident Updates (12) 08 Expansions (13) 09 QEHS (16) 10 Research & Development (17) 11 QIP Funds Utilisa
Slide 5: Aether Today
Aether Today 6,511 6,374 6,351 * 5,970 4,538 EBITDA % 30.4 Revenue 29.3 29.8 * 3,038 25.3 2,033 24.4 24.3 24.7 1,092 21.7 FY18 FY19 FY20 FY21 FY22 FY23 FY24 9MFY25 FY18 FY19 FY20 FY21 FY22 FY23 FY24 9MFY25 19.5 Export# PAT % LSM 54.5% 18.2 17.0 * Others 49.5% 15.7 1.2% 13.2 CRAMS 12.9 11.4% By Busin
Slide 6: Aether's Business Segments
Aether’s Business Segments Revenue Pharma Sustainability & Renewables 48.5% 0.4% Oil & Gas 4.1% Revenue Food Additives By Segment Pharma 0.8% 9M FY25 47.5% Multiple Sustainability & Renewables 8.8% 1.0% High Performance Photography Oil & Gas 2.8% Agro 4.3% Coatings 22.8% Food Additives By Segment 4.
Slide 7: Highlights
Agreement executed Site 2 Site 3++ Expansion order finalised, validation quantities Fully operational, post the revocation order site expansion on track and plans to manufactured, raw materials ordered and from GPCB, in Jan 2025 commission soon ramp-up from Q4-FY25 - Site 4 Site 5 Expansion Site 4 E
Slide 8: Business Models
Business Models 49% 38% 11% Large Scale Contract Research & Contract | Exclusive Manufacturing Manufacturing Services Manufacturing Advanced intermediates and Contract research, scale-up services, Manufacture under contractual speciality chemicals with application technology development, low volume
Slide 9: Y on Y Consolidated
Y on Y Consolidated Revenue EBITDA PAT Q3 FY25 2,333 757 32% 434 19% 40% 109% 149% Q3 FY24 1,666 362 22% 174 10% Y-o-Y is comparison of Q3 FY25 with Q3 FY24 All numbers are in INR MM (Consolidated)
Slide 10: Q on Q Consolidated
Q on Q Consolidated Revenue EBITDA PAT Q3 FY25 2,333 757 32% 434 19% 11% 23% 25% Q2 FY25 2,098 613 29% 348 17% Q on Q is Comparison of Q3 FY25 with Q2 FY25 All numbers are in INR MM (Consolidated)
Slide 11: 9MFY on 9MFY Consolidated
9MFY on 9MFY Consolidated Revenue EBITDA PAT 9MFY25 6,351 1,891 1,081 30% 17% 25% 32% 29% 5,083 1,433 839 28% 17% 9MFY24 9MFY-o-9MFY is comparison of 9MFY25 with 9MFY24 All numbers are in INR MM (Consolidated)
Slide 12: Solar Power Plant - Auto Tracker
Announcement Solar Power Plant - Auto Tracker Final execution and commissioning of 15MW Solar Power Project (Auto-Tracker Modules) successfully done. The project is now operational at full capacity and powering our manufacturing facilities. This milestone is anticipated to control energy overheads a
Slide 13: Accident Update: Site 2 has resumed fully and operational
Accident Update The Site 2 has resumed fully and operational GPCB approval received in January 2025, for the revocation of closure orders, which were given in November 2023.
Slide 14: Site 3++
Site 3++ • Site expansion - construction on schedule! • Equipment and machinery secured • Requisite approvals secured • Commissioning expected by end of FY25
Slide 15: Site 4
Site 4 • Site ready and commissioned in March 2024 • Agreement with customer in place • Commercial order finalised and validation batches commenced in Q3-FY25 • 8 Products to be launched currently - in phased manner
Slide 16: Site 5
Site 5 • EC approved in December 2023, ordering of equipment started • Ground digging, wall fencing and plinth work completed • Building work started for phase one production block • Phase one expected to be commissioned by end of FY26
Slide 17: QEHS
QEHS ISO 9001 Indian GMP 17%* ISO 45001 UN Global 7.05% - QC/QA/ADL Team. 4.60% - Safety Team ISO 14001 Ecovadis Medal 5.31% - Environment Team ISO 27001 28* times our facilities have been audited by Aether has implemented QEHS system. This includes Improved quality, Enhanced environmental performan
Slide 18: R&D expenses: Differentiating Factor
Differentiating Factor ₹ 987 (15.4%) R&D expenses 469.96 MM or 7.40% of total revenue in 9MFY25 ₹ 393 ₹ 501 (7.5%) (6.6%) ₹ 193 (4.3%) ₹ 121 (4%) ₹ 53 (2.6%) All numbers are in INR MM (Consolidated) FY19 FY20 FY21 FY22 FY23 FY24
Slide 19: Standalone Statement of Assets and Liabilities
Standalone Statement of Assets and Liabilities ASSETS 9M FY25 FY24 EQUITY AND LIABILITIES 9M FY25 FY24 Unaudited Audited Unaudited Audited Non-current assets Equity Property, plant and equipment Equity share capital 7,229 6,097 1,326 1,326 Capital work-in-progress Other equity 3,015 2,143 20,486 19,
Slide 20: Standalone Financial Results
Standalone Financial Results Particulars Q3FY25 Q2FY25 Q3FY24 9M FY25 9M FY24 FY24 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Revenue from operations 1,974 1,964 1,554 5,739 4,806 5,957 Other income 140 127 128 387 277 443 Total income 2,114 2,091 1,682 6,126 5,083 6,399 Cost of goods
Slide 21: Standalone Statement of Cash Flows
Standalone Statement of Cash Flows Particulars 9M FY25 FY24 Unaudited Audited Cash generated from operations 1196 153 Net cash from operating activities 926 (20) Net cash (used in) investing activities (2,638) (3,989) Net cash used in nancing activities 203 8,542 Net increase / (decrease) in cash an
Slide 22: Consolidated Statement of Assets and Liabilities
Consolidated Statement of Assets and Liabilities ASSETS 9M FY25 FY24 EQUITY AND LIABILITIES 9M FY25 FY24 Unaudited Audited Unaudited Audited Non-current assets Equity Property, plant and equipment Equity share capital 8,073 6,933 1,326 1,326 Capital work-in-progress Other equity 3,343 2,261 20,419 1
Slide 23: Consolidated Financial Results
Consolidated Financial Results Particulars Q3FY25 Q2FY25 Q3FY24 9M FY25 9M FY24 FY24 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Revenue from operations 2,197 1,988 1,554 5,985 4,806 5,982 Other income 136 110 113 366 277 392 Total income 2,333 2,098 1,666 6,351 5,083 6,374 Cost of goo
Slide 24: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows Particulars 9M FY25 FY24 Unaudited Audited Cash generated from operations 1261 8 Net cash from operating activities 991 (165) Net cash (used in) investing activities (2,880) (4,239) Net cash used in nancing activities 381 8,938 Net increase / (decrease) in cash a
Slide 25: Forward-looking statements notice
Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such forward -lo